Mutation Analysis of BRAF, MEK1 and MEK2 in 15 Ovarian Cancer Cell Lines: Implications for Therapy
Anne L. Estep(Cancer Research Institute), Katherine A. Rauen(University of California, Davis)
Cited by 94
Related Papers
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766
Diversity, parental germline origin, and phenotypic spectrum of de novo<i>HRAS</i>missense changes in Costello syndrome
|Human Mutation|2006|132
Costello syndrome: Clinical phenotype, genotype, and management guidelines
|American Journal of Medical Genetics Part A|2019|127
Periventricular heterotopia associated with chromosome 5p anomalies
|Neurology|2003|96
The <scp>8th International RASopathies Symposium</scp>: Expanding research and care practice through global collaboration and advocacy
|American Journal of Medical Genetics Part A|2023|7